ARTICLE | Clinical News

Antibodies modified with ultraviolet light regulatory update

April 17, 2000 7:00 AM UTC

AXO received notice of allowance for a U.S. patent covering the use of ultraviolet light to modify antibodies and enhance certain immune responses. AXO said the patent covers its OvaRex anti- CA125 m...